Selected research
Industry Research
Stem Cell Exosome Therapeutic Industry Research Report 2026
Market perspective
The global Stem Cell Exosome Therapeutic market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Stem Cell Exosome Therapeutic market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Stem Cell Exosome Therapeutic market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Stem Cell Exosome Therapeutic market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Stem Cell Exosome Therapeutic include CHA Biotech, ExoCoBio, Exopharm, OmniSpiant, BrainStorm Cell Therapeutics, Novadip Biosciences, Unicyte AG, Exogenus Therapeutics and Creative Medical Tech, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Stem Cell Exosome Therapeutic market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Stem Cell Exosome Therapeutic.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Stem Cell Exosome Therapeutic Market by Company
CHA Biotech
ExoCoBio
Exopharm
OmniSpiant
BrainStorm Cell Therapeutics
Novadip Biosciences
Unicyte AG
Exogenus Therapeutics
Creative Medical Tech
Anjarium Biosciences
Capricor Therapeutics
Kimera Labs ReNeuron
Stem Cell Medicine
Codiak Biosciencesare
Aegle Therapeutics
Brexogen
Cell Care Therapeutics
Stem Cell Exosome Therapeutic Segment by Type
Mesenchymal Stem Cell (MSC)
Dendritic Cells
Umbilical MSC
Others
Stem Cell Exosome Therapeutic Segment by Application
Precision Medicine
Regenerative Medicine
Others
Stem Cell Exosome Therapeutic Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Exosome Therapeutic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Exosome Therapeutic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Exosome Therapeutic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Stem Cell Exosome Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mesenchymal Stem Cell (MSC)
- Dendritic Cells
- Umbilical MSC
- Others
Applications
- Precision Medicine
- Regenerative Medicine
- Others
Companies covered
- CHA Biotech
- ExoCoBio
- Exopharm
- OmniSpiant
- BrainStorm Cell Therapeutics
- Novadip Biosciences
- Unicyte AG
- Exogenus Therapeutics
- Creative Medical Tech
- Anjarium Biosciences
- Capricor Therapeutics
- Kimera Labs ReNeuron
- Stem Cell Medicine
- Codiak Biosciencesare
- Aegle Therapeutics
- Brexogen
- Cell Care Therapeutics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Stem Cell Exosome Therapeutic by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Mesenchymal Stem Cell (MSC)
- 2.2.3 Dendritic Cells
- 2.2.4 Umbilical MSC
- 2.2.5 Others
- 2.3 Stem Cell Exosome Therapeutic by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Precision Medicine
- 2.3.3 Regenerative Medicine
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Stem Cell Exosome Therapeutic Breakdown Data by Type
- 3.1 Global Stem Cell Exosome Therapeutic Historic Market Size by Type (2021-2026)
- 3.2 Global Stem Cell Exosome Therapeutic Forecasted Market Size by Type (2027-2032)
4 Stem Cell Exosome Therapeutic Breakdown Data by Application
- 4.1 Global Stem Cell Exosome Therapeutic Historic Market Size by Application (2021-2026)
- 4.2 Global Stem Cell Exosome Therapeutic Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Stem Cell Exosome Therapeutic Market Perspective (2021-2032)
- 5.2 Global Stem Cell Exosome Therapeutic Growth Trends by Region
- 5.2.1 Global Stem Cell Exosome Therapeutic Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Stem Cell Exosome Therapeutic Historic Market Size by Region (2021-2026)
- 5.2.3 Stem Cell Exosome Therapeutic Forecasted Market Size by Region (2027-2032)
- 5.3 Stem Cell Exosome Therapeutic Market Dynamics
- 5.3.1 Stem Cell Exosome Therapeutic Industry Trends
- 5.3.2 Stem Cell Exosome Therapeutic Market Drivers
- 5.3.3 Stem Cell Exosome Therapeutic Market Challenges
- 5.3.4 Stem Cell Exosome Therapeutic Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Stem Cell Exosome Therapeutic Players by Revenue
- 6.1.1 Global Top Stem Cell Exosome Therapeutic Players by Revenue (2021-2026)
- 6.1.2 Global Stem Cell Exosome Therapeutic Revenue Market Share by Players (2021-2026)
- 6.2 Global Stem Cell Exosome Therapeutic Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Stem Cell Exosome Therapeutic Head Office and Area Served
- 6.4 Global Stem Cell Exosome Therapeutic Players, Product Type & Application
- 6.5 Global Stem Cell Exosome Therapeutic Manufacturers Established Date
- 6.6 Global Stem Cell Exosome Therapeutic Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Stem Cell Exosome Therapeutic Market Size (2021-2032)
- 7.2 North America Stem Cell Exosome Therapeutic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Stem Cell Exosome Therapeutic Market Size by Country (2021-2026)
- 7.4 North America Stem Cell Exosome Therapeutic Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Stem Cell Exosome Therapeutic Market Size (2021-2032)
- 8.2 Europe Stem Cell Exosome Therapeutic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Stem Cell Exosome Therapeutic Market Size by Country (2021-2026)
- 8.4 Europe Stem Cell Exosome Therapeutic Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Stem Cell Exosome Therapeutic Market Size (2021-2032)
- 9.2 Asia-Pacific Stem Cell Exosome Therapeutic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Stem Cell Exosome Therapeutic Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Stem Cell Exosome Therapeutic Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Stem Cell Exosome Therapeutic Market Size (2021-2032)
- 10.2 South America Stem Cell Exosome Therapeutic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Stem Cell Exosome Therapeutic Market Size by Country (2021-2026)
- 10.4 South America Stem Cell Exosome Therapeutic Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Stem Cell Exosome Therapeutic Market Size (2021-2032)
- 11.2 Middle East & Africa Stem Cell Exosome Therapeutic Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Stem Cell Exosome Therapeutic Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Stem Cell Exosome Therapeutic Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 CHA Biotech
- 12.1.1 CHA Biotech Company Information
- 12.1.2 CHA Biotech Business Overview
- 12.1.3 CHA Biotech Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.1.4 CHA Biotech Stem Cell Exosome Therapeutic Product Portfolio
- 12.1.5 CHA Biotech Recent Developments
- 12.2 ExoCoBio
- 12.2.1 ExoCoBio Company Information
- 12.2.2 ExoCoBio Business Overview
- 12.2.3 ExoCoBio Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.2.4 ExoCoBio Stem Cell Exosome Therapeutic Product Portfolio
- 12.2.5 ExoCoBio Recent Developments
- 12.3 Exopharm
- 12.3.1 Exopharm Company Information
- 12.3.2 Exopharm Business Overview
- 12.3.3 Exopharm Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.3.4 Exopharm Stem Cell Exosome Therapeutic Product Portfolio
- 12.3.5 Exopharm Recent Developments
- 12.4 OmniSpiant
- 12.4.1 OmniSpiant Company Information
- 12.4.2 OmniSpiant Business Overview
- 12.4.3 OmniSpiant Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.4.4 OmniSpiant Stem Cell Exosome Therapeutic Product Portfolio
- 12.4.5 OmniSpiant Recent Developments
- 12.5 BrainStorm Cell Therapeutics
- 12.5.1 BrainStorm Cell Therapeutics Company Information
- 12.5.2 BrainStorm Cell Therapeutics Business Overview
- 12.5.3 BrainStorm Cell Therapeutics Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.5.4 BrainStorm Cell Therapeutics Stem Cell Exosome Therapeutic Product Portfolio
- 12.5.5 BrainStorm Cell Therapeutics Recent Developments
- 12.6 Novadip Biosciences
- 12.6.1 Novadip Biosciences Company Information
- 12.6.2 Novadip Biosciences Business Overview
- 12.6.3 Novadip Biosciences Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.6.4 Novadip Biosciences Stem Cell Exosome Therapeutic Product Portfolio
- 12.6.5 Novadip Biosciences Recent Developments
- 12.7 Unicyte AG
- 12.7.1 Unicyte AG Company Information
- 12.7.2 Unicyte AG Business Overview
- 12.7.3 Unicyte AG Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.7.4 Unicyte AG Stem Cell Exosome Therapeutic Product Portfolio
- 12.7.5 Unicyte AG Recent Developments
- 12.8 Exogenus Therapeutics
- 12.8.1 Exogenus Therapeutics Company Information
- 12.8.2 Exogenus Therapeutics Business Overview
- 12.8.3 Exogenus Therapeutics Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.8.4 Exogenus Therapeutics Stem Cell Exosome Therapeutic Product Portfolio
- 12.8.5 Exogenus Therapeutics Recent Developments
- 12.9 Creative Medical Tech
- 12.9.1 Creative Medical Tech Company Information
- 12.9.2 Creative Medical Tech Business Overview
- 12.9.3 Creative Medical Tech Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.9.4 Creative Medical Tech Stem Cell Exosome Therapeutic Product Portfolio
- 12.9.5 Creative Medical Tech Recent Developments
- 12.10 Anjarium Biosciences
- 12.10.1 Anjarium Biosciences Company Information
- 12.10.2 Anjarium Biosciences Business Overview
- 12.10.3 Anjarium Biosciences Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.10.4 Anjarium Biosciences Stem Cell Exosome Therapeutic Product Portfolio
- 12.10.5 Anjarium Biosciences Recent Developments
- 12.11 Capricor Therapeutics
- 12.11.1 Capricor Therapeutics Company Information
- 12.11.2 Capricor Therapeutics Business Overview
- 12.11.3 Capricor Therapeutics Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.11.4 Capricor Therapeutics Stem Cell Exosome Therapeutic Product Portfolio
- 12.11.5 Capricor Therapeutics Recent Developments
- 12.12 Kimera Labs ReNeuron
- 12.12.1 Kimera Labs ReNeuron Company Information
- 12.12.2 Kimera Labs ReNeuron Business Overview
- 12.12.3 Kimera Labs ReNeuron Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.12.4 Kimera Labs ReNeuron Stem Cell Exosome Therapeutic Product Portfolio
- 12.12.5 Kimera Labs ReNeuron Recent Developments
- 12.13 Stem Cell Medicine
- 12.13.1 Stem Cell Medicine Company Information
- 12.13.2 Stem Cell Medicine Business Overview
- 12.13.3 Stem Cell Medicine Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.13.4 Stem Cell Medicine Stem Cell Exosome Therapeutic Product Portfolio
- 12.13.5 Stem Cell Medicine Recent Developments
- 12.14 Codiak Biosciencesare
- 12.14.1 Codiak Biosciencesare Company Information
- 12.14.2 Codiak Biosciencesare Business Overview
- 12.14.3 Codiak Biosciencesare Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.14.4 Codiak Biosciencesare Stem Cell Exosome Therapeutic Product Portfolio
- 12.14.5 Codiak Biosciencesare Recent Developments
- 12.15 Aegle Therapeutics
- 12.15.1 Aegle Therapeutics Company Information
- 12.15.2 Aegle Therapeutics Business Overview
- 12.15.3 Aegle Therapeutics Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.15.4 Aegle Therapeutics Stem Cell Exosome Therapeutic Product Portfolio
- 12.15.5 Aegle Therapeutics Recent Developments
- 12.16 Brexogen
- 12.16.1 Brexogen Company Information
- 12.16.2 Brexogen Business Overview
- 12.16.3 Brexogen Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.16.4 Brexogen Stem Cell Exosome Therapeutic Product Portfolio
- 12.16.5 Brexogen Recent Developments
- 12.17 Cell Care Therapeutics
- 12.17.1 Cell Care Therapeutics Company Information
- 12.17.2 Cell Care Therapeutics Business Overview
- 12.17.3 Cell Care Therapeutics Revenue in Stem Cell Exosome Therapeutic Business (2021-2026)
- 12.17.4 Cell Care Therapeutics Stem Cell Exosome Therapeutic Product Portfolio
- 12.17.5 Cell Care Therapeutics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst